Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):549-553. doi: 10.1002/ccd.29195. Epub 2020 Aug 13.
The use of transcatheter aortic valve replacement (TAVR) has expanded to patient populations of varying surgical risk in light of recent clinical trials, yet its role in patients with aortic stenosis and coexisting thoracic aortic aneurysm (TAA) is not well-delineated. We aimed to evaluate whether risk factors and in-hospital outcomes vary between TAVR patients with and without an unruptured TAA.
The Nationwide Readmissions Database was queried for patients hospitalized between January 2012 and December 2017 who underwent TAVR with and without an unruptured TAA. In-hospital outcomes were compared between cohorts after adjusting for sex, comorbidities, and TAVR approach, and in a subgroup analysis that excluded those with bicuspid aortic valves.
Among 171,011 TAVR patients, 1,677 (1%) presented with TAA. Patients with TAA were younger (median age 80 vs. 82 years, p < .001) and more likely to have bicuspid aortic valves (9.3% vs. 0.9%, p < .001). Among patients with aneurysm, 2.6% died, 2.2% developed stroke, 1% developed aortic dissection, and 1.4% experienced cardiac tamponade while hospitalized. After adjusting for age, sex, bicuspid aortic valve, and all comorbidities, TAA was associated with significantly higher risk of post-TAVR aortic dissection (OR = 2.117, 95% CI [1.304-3.435], p = .002) and cardiac tamponade (OR = 1.682, 95% CI [1.1-2.572], p = .02).
While the overall incidence of post-TAVR complications is low, patients with an unruptured TAA should be carefully considered by the Heart Team in weighing the additional risks of aortic dissection and cardiac tamponade after TAVR with those associated with surgery.
鉴于最近的临床试验,经导管主动脉瓣置换术(TAVR)的应用范围已经扩大到了不同手术风险的患者群体,但它在患有主动脉瓣狭窄和并存的胸主动脉瘤(TAA)的患者中的作用尚不清楚。我们旨在评估 TAVR 患者中是否存在 TAA 破裂的风险因素和住院结局不同。
从 2012 年 1 月至 2017 年 12 月,在全国再入院数据库中检索接受 TAVR 治疗且未破裂的 TAA 的患者。在调整性别、合并症和 TAVR 方法后,对两组患者的住院结局进行比较,并在排除二叶式主动脉瓣患者的亚组分析中进行比较。
在 171011 例 TAVR 患者中,1677 例(1%)出现 TAA。TAA 患者年龄较小(中位数 80 岁 vs. 82 岁,p<0.001),更有可能患有二叶式主动脉瓣(9.3% vs. 0.9%,p<0.001)。在动脉瘤患者中,2.6%死亡,2.2%发生卒中,1%发生主动脉夹层,1.4%发生心脏压塞。在校正年龄、性别、二叶式主动脉瓣和所有合并症后,TAA 与 TAVR 后主动脉夹层的风险显著增加相关(OR = 2.117,95%CI [1.304-3.435],p = 0.002)和心脏压塞(OR = 1.682,95%CI [1.1-2.572],p = 0.02)。
虽然 TAVR 后并发症的总体发生率较低,但 TAA 未破裂的患者应引起心脏团队的仔细考虑,权衡 TAVR 后主动脉夹层和心脏压塞的额外风险与手术相关的风险。